|
- Quick Guide - National Institute on Drug Abuse (NIDA)
WHY A QUICK GUIDE? This Quick Guide was developed to accompany Detoxification and Substance Abuse Treatment, Number 45 in the Treatment Improvement Protocol (TIP) series published by the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA) This Quick Guide is based entirely on TIP 45 and is designed to meet the needs of the busy
- Advancing reduction of drug use as an endpoint in addiction treatment . . .
It can pose a barrier to seeking and entering treatment and perpetuate stigma and shame at treatment setbacks By the same token, reduction of substance use has important public health benefits as well as clinical benefits for patients, and recognition of this could greatly advance medication development for treatment of addiction and its symptoms
- Principles of Adolescent Substance Use Disorder Treatment: A Research . . .
Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide Published in 2014, this report offered health professionals and other stakeholders information on principles of effective drug addiction treatment, answers to frequently asked questions, an overview of the drug addiction treatment landscape in the United States, and an outline of evidence-based treatment
- What are treatments for tobacco dependence? - National Institute on . . .
The prevalence of tobacco use and dependence among adolescents—as well as the neurobiological impact and medical consequences of nicotine exposure—suggest that pediatric primary care settings should deliver tobacco cessation treatments to both youth and parents who use tobacco 169 Current clinical guidance does not recommend medications for adolescent tobacco cessation because of a lack
- Addiction Treatment - National Institute on Drug Abuse (NIDA)
Addiction Treatment In 2021, approximately 43 7 million people aged 12 or older (15 6% of the population) needed substance use treatment in the past year However, only 6 8% of them received substance use treatment at a specialty facility (2021 DT 5 39B) *1 Review these research-based guides for helpful information on addiction treatment
- Methamphetamine | National Institute on Drug Abuse (NIDA)
Methamphetamine is a lab-made (synthetic) stimulant with high addiction potential When sold as shiny bluish-white rocks or crystals, it may be called “crystal meth,” “Tina,” or “ice ” Methamphetamine’s short-term effects typically include feelings of euphoria and increased alertness and energy It can also cause serious negative health effects, including paranoia, anxiety, rapid
- Treatment | National Institute on Drug Abuse (NIDA)
Opioid treatment programs provide evidence-based care for opioid use disorder They may be residential or outpatient facilities They usually include treatment with medications like methadone, buprenorphine, or naltrexone, combined with behavioral therapies
- Medications for Opioid Use Disorder - National Institute on Drug Abuse . . .
Information on how to get treatment for opioid use disorder from the Substance Abuse and Mental Health Services Administration (SAMHSA) How to participate in a NIDA-funded clinical trial on medications for opioid use disorder More information from SAMHSA on medications and other treatment options for substance use disorders
|
|
|